Related references
Note: Only part of the references are listed.Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis
Suetonia C. Palmer et al.
ANNALS OF INTERNAL MEDICINE (2012)
Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease
Nina Raju et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Lipid lowering in patients with chronic kidney disease: a SHARP turn in the wrong direction?
Heiner K. Berthold et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2011)
Aspirin resistance in patients with chronic renal failure
Azra Meryem Tanrikulu et al.
JOURNAL OF NEPHROLOGY (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
Giovanni F. M. Strippoli et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis
George Krasopoulos et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Universal definition of myocardial infarction
Kristian Thygesen et al.
CIRCULATION (2007)
Aspirin prescription and outcomes in hemodialysis patients:: The dialysis outcomes and practice patterns study (DOPPS)
Jean Ethier et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European society of cardiology
Jean-Pierre Bassand et al.
EUROPEAN HEART JOURNAL (2007)
From pathophysiology to targeted therapy for atherothrombosis: A role for the combination of statin and aspirin in secondary prevention
M. John Chapman
PHARMACOLOGY & THERAPEUTICS (2007)
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease
D. Charytan et al.
KIDNEY INTERNATIONAL (2006)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department - A Scientific Statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration with the Society of Chest Pain Centers
WB Gibler et al.
CIRCULATION (2005)
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease - Randomized and observational comparisons of secondary prevention trials and their meta-analyses
CH Hennekens et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
NS Anavekar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Association of statin therapy with outcomes of acute coronary syndromes: The GRACE Study
FA Spencer et al.
ANNALS OF INTERNAL MEDICINE (2004)
Task force 1: The ACCF and AHA codes of conduct in human subjects research
RJ Adams et al.
CIRCULATION (2004)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Management of acute myocardial infarction in patients presenting with ST-segment elevation
F Van de Werf et al.
EUROPEAN HEART JOURNAL (2003)
Impact of Aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The global registry of acute coronary events [GRACE])
FA Spencer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Share Paper
